Σφακιανάκης Αλέξανδρος
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5 Άγιος Νικόλαος
Κρήτη 72100
00302841026182
00306932607174
alsfakia@gmail.com

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Σάββατο 12 Μαρτίου 2016

THYROID STIMULATING ANTIBODIES ARE HIGHLY PREVALENT IN HASHIMOTO'S THYROIDITIS AND ASSOCIATED ORBITOPATHY.

THYROID STIMULATING ANTIBODIES ARE HIGHLY PREVALENT IN HASHIMOTO'S THYROIDITIS AND ASSOCIATED ORBITOPATHY.

J Clin Endocrinol Metab. 2016 Mar 10;:jc20161220

Authors: Kahaly GJ, Diana T, Glang J, Kanitz M, Pitz S, König J

Abstract
CONTEXT: Thyroid-associated orbitopathy (TAO) rarely occurs in patients with Hashimoto's thyroiditis (HT).
OBJECTIVE: There is evidence that TSH receptor (TSHR) stimulating antibodies (TSAb) play a role in the pathogenesis of TAO. In this report, the prevalence of TSAb in HT patients with and without TAO was studied.
DESIGN: Longitudinal observational study Setting: Academic joint thyroid-eye clinic Subjects: A total of 1055 subjects were included Methods: TSAb was measured with a FDA-cleared bioassay that utilizes CHO cells expressing a chimeric TSHR and a cAMP response element-dependent luciferase. Results of TSAb activity were reported as percentage of specimen-to-reference ratio (SRR%, cut-off >140%).
MAIN OUTCOME MEASURE: Association of TSAb with the risk of TAO in patients with HT.
RESULTS: Of 700 consecutive and unselected patients with HT, 44 (6%) had overt TAO. Patients with HT+TAO were older (p<0.001), heavy smoker (p=0.032), and clustered less with autoimmune diseases (p=0.005). All healthy controls were TSAb negative. In contrast, serum was TSAb positive in 30/44 (68.2%) and 36/656 (5.5%, p<0.001) patients with HT+TAO and HT, respectively. Compared to patients with HT only, serum TSAb levels were higher in HT+TAO (Median SRR%, 25% and 75% percentile): 45, 35-65 vs. 192.5, 115-455.3, p<0.001. Highest TSAb values were noted in patients with active and severe TAO versus those with mild and inactive TAO: 486, 392-592 versus 142, 73-192.5, p<0.001. The odds ratio (OR) of TSAb-positivity for the risk of TAO adjusted for gender and age was 55.9 (95% CI 24.6-127, p<0.0001), while the OR per ten-fold change in TSAb SRR% (quantitative TSAb) was 133 (95% CI 45-390, p<0.0001). The area under the ROC-curve for qualitative and quantitative TSAb was 87.2% (95% CI 80.6-93.8) and 89.4% (95% CI 84.1-94.7), respectively.
CONCLUSIONS: TSAb is strongly associated with TAO in HT and TSAb may contribute to the pathophysiology of TAO.

PMID: 26964732 [PubMed - as supplied by publisher]



from thyroid via a.lsfakia on Inoreader http://ift.tt/1RWltUY
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1QOrYdg
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου